A shuttered Milanese manufacturing site with a storied history is getting a new lease on life, thanks to a nearly half-a-billion-dollar investment from Italian drugmaker Chiesi. As part of an ongoing ...
Agreement builds on existing Chiesi-Bespak collaboration, reinforcing a trusted relationship as Chiesi works to evolve a portfolio of extrafine formulation Carbon Minimal Inhalers 1, ensuring patients ...
Findings showed BDP/FF/G improved predose FEV1 and reduced the rate of moderate to severe exacerbations compared with BDP/FF. The Food and Drug Administration (FDA) has accepted for review the New ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Chiesi USA's asthma inhaler ...
Asthma is a chronic respiratory condition that seriously affects millions of men, women, and children across the world. But the news is, it can be effectively managed with the right treatment. Central ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results